Browse studies

Find your next paid study

27,270 recruiting studies available now

Newest first Highest paying

Phase 2

Phase II Trial of Sacituzumab Govitecan in Recurrent and/or Metastatic Secretory Gland Cancers

To learn if sacituzumab govitecan can help to control salivary gland cancer.

GlandSalivary Gland Cancers

Estimated

~$75 – $2,000

Actual pay is set by the research site.

M.D. Anderson Cancer CenterNCT05884320

Electrographic Seizure Management and Neurobehavioral Outcomes in Critically Ill Children

Electrographic seizures are common in critically ill patients leading to increased use of resource-intense continuous EEG monitoring for seizure identification…

Seizures

Estimated

~$10 – $750

Actual pay is set by the research site.

Children's Hospital of PhiladelphiaNCT03419260

Observational

A Feasibility Study to Examine the Impact of Remotely Monitored Exercise Interventions on Cardiorespiratory/Muscular Fitness and Fatigue in Patients With Metastatic Castrate-sensitive Prostate Cancer (mCSPC) Undergoing Treatment With Androgen-deprivation Therapy (ADT) Intensification

This study consists of two home-based exercise programs: a stationary exercise bicycle intervention (Arm A), and a walking intervention (Arm B). The study will…

Castrate Sensitive Prostate CancerMetastatic Prostate Cancer

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Paul ViscuseNCT06429813

Genetic Studies of Chronic Active Epstein-Barr Virus Infection

Epstein-Barr virus (EBV) is a member of the human herpes virus family that infects more than 95 percent of the U.S. population. Most infections occur in childh…

Chronic Active Epstein-Barr Virus

Estimated

~$10 – $675

Actual pay is set by the research site.

National Institute of Allergy and Infectious Diseases (NIAID)NCT00032513

Phase 1

Phase 1/2 Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer

Assessment of the safety and efficacy of HLD-0915 (JNJ-101556143) in patients with metastatic prostate cancer who have progressed on prior systemic therapies, …

Metastatic Prostate Cancer

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Janssen Research & Development, LLCNCT06800313

International (Pediatric) Peritoneal Biobank

Within few years the peritoneal membrane of adult peritoneal dialysis (PD) patients undergoes substantial morphological transformation, including progressive f…

Kidney Failure, ChronicPeritoneal Dialysis ComplicationTransplantation+1 more

Estimated

~$10 – $750

Actual pay is set by the research site.

Heidelberg UniversityNCT01893710

A Prospective, Multicenter Study to Compare and Validate Endoscopic, Histologic, Molecular, and Patient-Reported Outcomes in Pediatric and Adult Patients With Eosinophilic Esophagitis (EoE), Gastritis (EoG), Enteritis (EoN) and Colitis (EoC)

The purpose of this observational study is to find the best measures to define how well a person with eosinophilic disorder is doing. People with EoE, EoG, EoN…

Eosinophilic Gastrointestinal Disorders (EGIDs)Eosinophilic EsophagitisEosinophilic Gastritis+2 more

Estimated

~$10 – $675

Actual pay is set by the research site.

Children's Hospital Medical Center, CincinnatiNCT02523118

Observational

Human Hippocampal Oscillations During Visuomotor Exploration

The objective of this study is to determine how visuomotor exploration relates to hippocampal activity along its long axis. The study will investigate the neur…

Epilepsy

Estimated

~$10 – $1,125

Actual pay is set by the research site.

NYU Langone HealthNCT07224191

Phase 1

A Study to Evaluate the Safety and Tolerability of the Covalent Phosphoinositide-3-Kinase (PI3K)-Alpha Inhibitor, TOS-358, in Adult Subjects With Select Solid Tumors

The goal of this clinical trial is to evaluate the safety and efficacy of TOS-358 in women with HR+ HER2- metastatic breast cancer whose tumors have a mutation…

HR+/HER2-negative Breast Cancer

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Totus MedicinesNCT05683418

Phase 1

A First in Human, Phase 1, Open-Label Study on the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of 4A10 Monotherapy In Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

ALT-101 is a first-in-human Phase 1 clinical trial testing a new antibody drug called 4A10 in patients with relapsed or hard-to-treat acute lymphoblastic leuke…

Lymphoblastic LymphomaAcute Lymphoblastic Leukemia ALL

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Allterum Therapeutics, IncNCT07586618

Phase 1

Zotatifin And EIF4A Platinum Helix Inhibition In Resistant AdvancedTNBC

To find the optimal (best) recommended dose of zotatifin and carboplatin to treat patients with metastatic or recurrent TNBC.

Phase IBZotatifinEIF4A+2 more

Estimated

~$150 – $3,000

Actual pay is set by the research site.

M.D. Anderson Cancer CenterNCT07783659

Observational

Impact Trial of Helping Educational Leaders Mobilize Evidence

Social, emotional, and behavioral (SEB) problems occur frequently among elementary school students, dramatically impede student outcomes, and have been exacerb…

Child DevelopmentChild Behavior

Estimated

~$10 – $750

Actual pay is set by the research site.

University of WashingtonNCT06586723